| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSTL | Common Stock | Sale | -$62.6K | -2.75K | -4.25% | $22.74 | 61.9K | Feb 5, 2024 | By LLC | F1, F2, F3 |
| transaction | CSTL | Common Stock | Sale | -$67.4K | -2.96K | -7.08% | $22.74 | 38.9K | Feb 5, 2024 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F2, F4 |
| transaction | CSTL | Common Stock | Sale | -$67.4K | -2.96K | -7.08% | $22.74 | 38.9K | Feb 5, 2024 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F2, F5 |
| transaction | CSTL | Common Stock | Sale | -$20.2K | -863 | -1.39% | $23.42 | 61.1K | Feb 5, 2024 | By LLC | F1, F3, F6 |
| transaction | CSTL | Common Stock | Sale | -$21.8K | -930 | -2.39% | $23.42 | 37.9K | Feb 5, 2024 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F6 |
| transaction | CSTL | Common Stock | Sale | -$21.8K | -931 | -2.39% | $23.42 | 38K | Feb 5, 2024 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F6 |
| transaction | CSTL | Common Stock | Sale | -$73.7K | -3.12K | -5.11% | $23.63 | 58K | Feb 6, 2024 | By LLC | F1, F3, F7 |
| transaction | CSTL | Common Stock | Sale | -$79.4K | -3.36K | -8.86% | $23.63 | 34.6K | Feb 6, 2024 | By Daniel Bradbury Irrecovable Descendant's Trust | F1, F4, F7 |
| transaction | CSTL | Common Stock | Sale | -$79.5K | -3.36K | -8.86% | $23.63 | 34.6K | Feb 6, 2024 | By Annette Bradbury Irrecovable Descendant's Trust | F1, F5, F7 |
| holding | CSTL | Common Stock | 4.66K | Feb 5, 2024 | Direct |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. |
| F2 | This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. |
| F4 | Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F5 | Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F6 | This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |